Stiles Financial Services Inc Sells 182 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stiles Financial Services Inc lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,755 shares of the medical equipment provider’s stock after selling 182 shares during the quarter. Stiles Financial Services Inc’s holdings in Intuitive Surgical were worth $2,482,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at approximately $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.9 %

Shares of ISRG opened at $582.98 on Monday. The firm has a fifty day simple moving average of $554.85 and a two-hundred day simple moving average of $514.38. The firm has a market cap of $207.65 billion, a PE ratio of 90.95, a P/E/G ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,671 shares of company stock valued at $3,188,254 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.